A new study published online in the Journal of the American Dietetic Association reveals that consumption of four fruits and vegetables accounts for the majority of selected phytonutrient intake by U.S. adults. The paper is entitled
Symptoms improved significantly in adults with the bleeding disorder hemophilia B following a single treatment with gene therapy developed by researchers at St. Jude Children’s Research Hospital in Memphis and demonstrated to be safe in a clinical trial conducted at the University College London (UCL) in the U.K.
The findings of the six-person study mark the first proof that gene therapy can reduce disabling, painful bleeding episodes in patients with the inherited blood disorder. Results of the Phase I study appear in the December 10 online edition of the New England Journal of Medicine. The research is also scheduled to be presented December 11 at the 53rd annual meeting of the American Society of Hematology in San Diego.
To view Multimedia News Release, go to http://www.multivu.com/mnr/46766-st-jude-children-s-research-hospital-gene-therapy-bleeding-disorder
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
Miramar Labs today announced that the miraDry System for the treatment of primary axillary hyperhidrosis, commonly known as excessive underarm sweat, is now available to select physicians in the U.S. The miraDry procedure provides a safe and lasting solution for this debilitating condition.
The U.S. Food & Drug Administration granted clearance for miraDry following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics and followed them 12-months post treatment. The miraDry System delivers energy non-invasively to the area under the arm where the sweat glands reside which creates localized heat to destroy and eliminate the glands. Since sweat glands do not regenerate, results are lasting.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54021-miramar-labs-miradry-treat-excessive-underarm-sweat-axillary-hyperhidrosis
Northwestern Mutual’s latest Cost of Long-Term Care study, released today, reveals consistently high costs for home health care, assisted living and nursing home care across the nation, underscoring the critical need to address long-term care as part of financial security planning.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53641-northwestern-mutual-cost-of-long-term-care-study-caregiving
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according to a paper published online today in Radiology. This is consistent with results of the ACRIN National CT Colonography Trial, published in the New England Journal of Medicine in 2008, which demonstrated that CT colonography can serve as a primary colorectal cancer screening option for adults ages 50 and older, but did not specifically break out data for participants ages 65 and older included in the overall analysis. The Centers for Medicare and Medicaid Services have deferred coverage for CT colonography, primarily citing a lack of data on the exam’s performance in Medicare-eligible recipients ages 65 and older.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54777-acrin-national-ct-colonography-study-radiology-cancer-screening-seniors
Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly understood link between treatment outcome and age at diagnosis.
The study involved 104 infants, children and young adults with advanced neuroblastoma, a cancer of the sympathetic nervous system. Investigators discovered the ATRX gene was mutated only in patients age 5 and older. The alterations occurred most often in patients age 12 and older. These older patients were also more likely than their younger counterparts to have a chronic form of neuroblastoma and die years after their disease is diagnosed.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52992-st-jude-pediatric-cancer-genome-project-neuroblastoma-research
Installing child restraints can frustrate even the most capable of parents. A system called Lower Anchors and Tethers for Children is supposed to make things easier by standardizing attachment hardware, but a new study shows that many automakers aren’t paying attention to the key factors that make LATCH work. Only 21 of the 98 top-selling 2010-11 model passenger vehicles evaluated have LATCH designs that are easy to use. This is the main finding of joint research conducted by the Insurance Institute for Highway Safety and the University of Michigan Transportation Research Institute (UMTRI).
In collaboration with the National Institutes of Health (NIH), Banner Alzheimer’s Institute (BAI), University of Antioquia in Colombia and Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announce the first-ever prevention trial in cognitively healthy individuals who are destined to develop Alzheimer’s disease because of their genetic history. This groundbreaking study—the first to investigate whether an anti-amyloid treatment can stave off the disease—will span two countries and help launch a new era of prevention research in the urgent fight against Alzheimer’s.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56128-banner-alzheimer-s-institute-genentech-nih-prevention-trial-genetics
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
A landmark summer research study has unveiled a vital component of wellness and happiness…vacations. The survey, “The Takeaways from Getaways,” commissioned by the Las Vegas Convention and Visitors Authority, draws attention to the serious physical and emotional implications of stress and feeling over worked, and the inextricable link between vacation and personal wellness and happiness.
The research revealed surprisingly that more than 9 out of 10 Americans reported feeling happier after taking a vacation. And seventy-seven percent (77%) believed that their overall health improves after a getaway. Even so, more than half of Americans admitted that doctors should be able to prescribe vacations as a curative and therapeutic option for stress-related maladies.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56160-the-takeaways-from-getaways-visit-las-vegas-lvcva
Melissa d’Arabian – celebrity chef, TV host and busy mother of four – and Dr. William Castelli – renowned cardiovascular specialist and former Director of the Framingham Heart study – announced today the launch of Get Real About Seafood, an educational campaign to raise awareness about the heart and brain health benefits of seafood and provide resources to help people eat a seafood-rich diet. On average, Americans eat about half the recommended 2 to 3 seafood servings each week due to a lack of understanding about health benefits and lack of confidence in selecting or preparing seafood.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55945-melissa-d-arabian-and-doctor-william-castelli-get-real-about-seafood
